Correlation Between Pfizer and WisdomTree Emerging
Does pairing Pfizer Inc with WisdomTree Emerging Markets lower idiosyncratic risk? Correlation context here helps quantify the diversifiable risk between Pfizer Inc and WisdomTree Emerging Markets.
This page measures how tightly Pfizer Inc and WisdomTree Emerging Markets returns move together and where diversification can still help. You can also test a long Pfizer and short WisdomTree Emerging structure to evaluate relative-value behavior. Review volatility patterns in Pfizer and WisdomTree Emerging. Go to your portfolio center
Diversification Opportunities for Pfizer and WisdomTree Emerging
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Pfizer and WisdomTree is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and WisdomTree Emerging Markets in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WisdomTree Emerging and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with WisdomTree Emerging. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WisdomTree Emerging has no effect on the direction of Pfizer i.e., Pfizer and WisdomTree Emerging go up and down completely randomly.
Pair Corralation between Pfizer and WisdomTree Emerging
Considering the 90-day investment horizon Pfizer Inc is expected to generate 1.52 times more return on investment than WisdomTree Emerging. However, Pfizer is 1.52 times more volatile than WisdomTree Emerging Markets. It trades about 0.13 of its potential returns per unit of risk. WisdomTree Emerging Markets is currently generating about 0.11 per unit of risk. If you had invested $ 2,478 in Pfizer Inc on December 19, 2025 and sold it today you would have earned a total of $ 255.00 from holding Pfizer Inc or generated 10.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. WisdomTree Emerging Markets
Performance |
| Timeline |
| Pfizer Inc |
Risk-Adjusted Performance
Moderate
Weak | Strong |
| WisdomTree Emerging |
Risk-Adjusted Performance
Moderate
Weak | Strong |
Pfizer and WisdomTree Emerging Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and WisdomTree Emerging
Pair trading between Pfizer and WisdomTree Emerging can reduce some unsystematic risk by balancing one position against another. Used correctly, the structure can help offset losses in one leg when unexpected sector or market pressure hits both names.| Pfizer vs. Gilead Sciences | Pfizer vs. Sanofi ADR | Pfizer vs. Amgen Inc | Pfizer vs. GlaxoSmithKline PLC ADR |
| WisdomTree Emerging vs. WisdomTree MidCap Dividend | WisdomTree Emerging vs. iShares Home Construction | WisdomTree Emerging vs. iShares MSCI All | WisdomTree Emerging vs. WisdomTree India Earnings |
Go to your portfolio centerThe analysis presented here should support, not replace, the broader process of selecting and combining portfolio holdings. The practical goal is to improve the mix of assets already under consideration. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |